Controversies in the management of Graves' disease in children (Q38827752)

6 September 2017

1 reference

title

Controversies in the management of Graves' disease in children (English)

1 reference

6 September 2017

1 reference

S A Rivkees

1

1 reference

6 September 2017

publication date

6 May 2016

1 reference

Journal of Endocrinological Investigation

6 September 2017

published in

1 reference

6 September 2017

volume

39

1 reference

6 September 2017

issue

11

1 reference

6 September 2017

page(s)

1247-1257

1 reference

Role of genetic and non-genetic factors in the etiology of Graves' disease.

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Current Insights into the Pathogenesis of Graves' Ophthalmopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Extrathyroidal manifestations of Graves' disease: a 2014 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Positive Impact of Long-Term Antithyroid Drug Treatment on the Outcome of Children with Graves' Disease: National Long-Term Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Increasing Incidence of Juvenile Thyrotoxicosis in Denmark: A Nationwide Study, 1998-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Management of hyperthyroidism in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Autoimmune Hyperthyroidism in Prepubertal Children and Adolescents: Comparison of Clinical and Biochemical Features at Diagnosis and Responses to Medical Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

63 years and 715 days to the "boxed warning": unmasking of the propylthiouracil problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Ending propylthiouracil-induced liver failure in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Graves disease in childhood: a review of the options for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Effective methimazole dose for childhood Graves' disease and use of free triiodothyronine combined with concurrent thyroid-stimulating hormone level to identify mild hyperthyroidism and delayed pituitary recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drug regimen for treating Graves' hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Methimazole-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid Drugs and Graves' Disease: A Prospective Randomized Evaluation of the Efficacy of Treatment Duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Association between TSH-Receptor Autoimmunity, Hyperthyroidism, Goitre, and Orbitopathy in 208 Patients Included in the Remission Induction and Sustenance in Graves' Disease Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Cancer risk in patients with Graves' disease: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

ANCA antibodies in Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antineutrophil cytoplasmic antibodies (ANCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Do Young Adults Have Unmet Healthcare Needs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Saul Hertz, MD (1905-1950): a pioneer in the use of radioactive iodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Influence of iodine-131 dose on the outcome of hyperthyroidism in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Thyroid storm following radioactive iodine (RAI) therapy for pediatric graves disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Complications of radioiodine treatment of hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Long-Term Follow-up Results in Children and Adolescents Treated with Radioactive Iodine (131I) for Hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drug therapy for toxic diffuse goiter (Graves disease): Thirty years experience in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Cancer risk after iodine-131 therapy for hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Thyroid function and mortality in patients treated for hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Increased cancer incidence after radioiodine treatment for hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Graves' disease in children and adolescents. Late results of surgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Clinical and economic outcomes of thyroid and parathyroid surgery in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Effect of patient Age on surgical outcomes for Graves' disease: a case-control study of 100 consecutive patients at a high volume thyroid surgical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Should total thyroidectomy become the preferred procedure for surgical management of Graves' disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Advantages and disadvantages of surgical therapy and optimal extent of thyroidectomy for the treatment of hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

The importance of surgeon experience for clinical and economic outcomes from thyroidectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Surgical management of pediatric Graves’ disease: an effective definitive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Treatment of Graves' Hyperthyroidism with Radioiodine: Results of a Prospective Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40618-016-0477-X

Grave's disease 1835-2002.

21 January 2018

1 reference

12 December 2020

Adverse events associated with methimazole therapy of graves' disease in children.

1 reference

12 December 2020

Radioactive iodine treatment of Graves' disease. Results in 32 children under 16 years of age

1 reference

12 December 2020

Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission?

1 reference

12 December 2020

Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer

1 reference

12 December 2020

Pediatric Gravesʼ Disease: Therapeutic Options and Experience With Radioiodine at the University of Mississippi Medical Center

1 reference

12 December 2020

The ablation of normal thyroid tissue with iodine 131

1 reference

12 December 2020

Drugs associated with vasculitis

1 reference

12 December 2020

Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment.

1 reference

12 December 2020

Radioiodine treatment of Graves' disease. An assessment of its potential risks

1 reference

12 December 2020

Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?

1 reference

12 December 2020

What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves’ disease

1 reference

12 December 2020

Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children

1 reference

12 December 2020

Mortality and vascular outcomes in patients treated for thyroid dysfunction

1 reference

12 December 2020

Long-term outcomes of pediatric Graves' disease

1 reference

12 December 2020

Diagnosis and management of juvenile hyperthyroidism in Germany: a retrospective multicenter study

1 reference

12 December 2020

Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy

1 reference

12 December 2020

TREATMENT OF HYPERTHYROIDISM IN CHILDREN. ANALYSIS OF FORTY-FIVE PATIENTS

1 reference

12 December 2020

Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism

1 reference

12 December 2020

Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication

1 reference

12 December 2020

Surgical treatment of Graves' disease: subtotal or total thyroidectomy?

1 reference

12 December 2020

Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose

1 reference

12 December 2020

Treatment for childhood-onset Graves' disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists

1 reference

12 December 2020

How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?

1 reference

12 December 2020

Hyperthyroidism in children. A reevaluation of treatment

1 reference

12 December 2020

Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients

1 reference

12 December 2020

Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine

1 reference

12 December 2020

Single Daily Dose of Methimazole Compared to Every 8 Hours Propylthiouracil in the Treatment of Hyperthyroidism

1 reference

12 December 2020

Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment

1 reference

12 December 2020

Later results of 131-I treatment of hyperthyroidism in 73 children and adolescents: 1967 followup

1 reference

12 December 2020

Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?

1 reference

12 December 2020

Thyroid surgery in children and teenagers

1 reference

12 December 2020

Radiation-induced thyroid cancer--what's new?

1 reference

12 December 2020

Predictors of early remission of hyperthyroidism in children

1 reference

12 December 2020

LATE RESULTS OF I-131 TREATMENT OF HYPERTHYROIDISM IN SEVENTY-THREE CHILDREN AND ADOLESCENTS

1 reference

12 December 2020

Thyroid cancer and Graves' disease: the controversy ten years later

1 reference

12 December 2020

Pediatric Graves' disease: outcome and treatment

1 reference

12 December 2020

Treatment of hyperthyroidism with a large initial dose of sodium iodide I 131

1 reference

12 December 2020

A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients

1 reference

12 December 2020

Cancer mortality in women with thyroid disease

1 reference

12 December 2020

The Risk of Thyroid Cancers Following Irradiation

1 reference

12 December 2020

Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication

1 reference

12 December 2020

Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial

1 reference

12 December 2020

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

1 reference

12 December 2020

Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use

1 reference

12 December 2020

Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer

1 reference

12 December 2020

Access to health care for adolescents and young adults

1 reference

12 December 2020

History of the Discovery and Early Use of Radioactive Iodine

1 reference

12 December 2020

10.1007/S40618-016-0477-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1046066886

0 references

1 reference